HighTower Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

HighTower Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+3,308	New	+$194K	﹤0.01%	3468
2023 Q1	–	Sell	-35,641	Closed	-$1.46M	–	3699
2022 Q4	$1.46M	Buy	+35,641	New	+$1.48M	﹤0.01%	1456
2021 Q3	–	Sell	-16,161	Closed	-$836K	–	3465
2021 Q2	$836K	Sell	16,161 -33,866	-68%	-$1.7M	﹤0.01%	1753
2021 Q1	$2.52M	Sell	50,027 -92	-0.2%	-$4.9K	0.01%	1015
2020 Q4	$2.61M	Sell	50,119 -1,053	-2%	-$50.4K	0.01%	799
2020 Q3	$2.23M	Buy	+51,172	New	+$2.24M	0.01%	840
2018 Q4	–	Sell	-327,271	Closed	-$15.9M	–	2385
2018 Q3	$15.9M	Buy	+327,271	New	+$15.5M	0.11%	195
2017 Q3	–	Sell	-5,749	Closed	-$247K	–	2370
2017 Q2	$247K	Buy	5,749 +1	+0%	+$42	﹤0.01%	1742
2017 Q1	$240K	Buy	5,748 +200	+4%	+$8.15K	﹤0.01%	1672
2016 Q4	$217K	Sell	5,548 -200	-3%	-$8.14K	﹤0.01%	1640
2016 Q3	$255K	Buy	5,748 +100	+2%	+$4.54K	﹤0.01%	1530
2016 Q2	$236K	Hold	5,648	–	–	﹤0.01%	1420
2016 Q1	$226K	Sell	5,648 -23,427	-81%	-$993K	﹤0.01%	1757
2015 Q4	$1.49M	Sell	29,075 -1,449	-5%	-$73.8K	0.02%	757
2015 Q3	$1.43M	Sell	30,524 -30,482	-50%	-$1.84M	0.02%	730
2015 Q2	$3.8M	Sell	61,006 -10,712	-15%	-$667K	0.06%	339
2015 Q1	$4.43M	Buy	71,718 +7,698	+12%	+$456K	0.07%	328
2014 Q4	$3.46M	Buy	64,020 +868	+1%	+$47.4K	0.05%	393
2014 Q3	$3.35M	Sell	63,152 -1,950	-3%	-$99.1K	0.06%	363
2014 Q2	$3.38M	Sell	65,102 -9,240	-12%	-$446K	0.06%	363
2014 Q1	$3.48M	Buy	74,342 +7,112	+11%	+$336K	0.07%	334
2013 Q4	$2.96M	Sell	67,230 -12,686	-16%	-$528K	0.06%	344
2013 Q3	$3.08M	Buy	79,916 +8,810	+12%	+$333K	0.08%	294
2013 Q2	$2.51M	Buy	+71,106	New	+$2.4M	0.07%	310

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HighTower Advisors's XPH Position: Q2 2026 in Review

HighTower Advisors opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2026: 3,308 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #3468 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in XPH as recently as Q4 2022.

HighTower Advisors first reported a position in XPH in Q2 2013 and has held it in 24 quarters since. The position peaked at $15.9M in Q3 2018. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

HighTower Advisors held 3,308 shares of State Street SPDR S&P Pharmaceuticals ETF worth $219K as of Q2 2026.
State Street SPDR S&P Pharmaceuticals ETF was a new HighTower Advisors position in Q2 2026.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3468 holding.
HighTower Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 24 quarters since.
HighTower Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $15.9M in Q3 2018.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.